DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado and currently employs 76,000 full-time employees. The firm is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. The company also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Follow-Up Questions
What is DaVita Inc (DVA)'s P/E Ratio?
The P/E ratio of DaVita Inc is 9.4504
Who is the CEO of DaVita Inc?
Mr. Javier Rodriguez is the Chief Executive Officer of DaVita Inc, joining the firm since 2000.
What is the price performance of DVA stock?
The current price of DVA is $120.4, it has decreased 0% in the last trading day.
What are the primary business themes or industries for DaVita Inc?
DaVita Inc belongs to Health Care industry and the sector is Health Care
What is DaVita Inc market cap?
DaVita Inc's current market cap is $8.6B
Is DaVita Inc a buy, sell, or hold?
According to wall street analysts, 10 analysts have made analyst ratings for DaVita Inc, including 0 strong buy, 1 buy, 10 hold, 5 sell, and 0 strong sell
